Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19685956 | 0.91 | ACHE (0.41) | ACHECYP1A1CYP1A2CYP1B1ALDH1A1 | |
| SCHEMBL19685900 | 0.88 | ACHE (0.36) | ACHECYP1A1CYP1A2CYP1B1ALDH1A1 | |
| SCHEMBL19685788 | 0.86 | ACHE (0.37) | ACHECYP1A1CYP1A2CYP1B1ALDH1A1 | |
| SCHEMBL19685894 | 0.85 | ACHE (0.38) | ACHECYP1A1CYP1A2CYP1B1ALDH1A1 | |
| SCHEMBL17752252 | 0.85 | PTGER4 (0.37) | ACHEALDH1A1HPGDKDM4EHDAC6 | |
| SCHEMBL17752249 | 0.82 | MAOA (0.42) | ALDH1A1HPGDKDM4E | |
| SCHEMBL19685951 | 0.82 | ALDH1A1 (0.36) | ACHECYP1A1CYP1A2CYP1B1ALDH1A1 | |
| SCHEMBL19685952 | 0.80 | ALDH1A1 (0.34) | ACHECYP1A1CYP1A2CYP1B1ALDH1A1 | |
| SCHEMBL19685678 | 0.80 | KDM4E (0.35) | ALDH1A1HPGDKDM4E | |
| SCHEMBL18926130 | 0.80 | PTGER4 (0.33) | ALDH1A1HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-14 | — | — | US | disclosed |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | CYC1, CCNA1, CYCS | ACHE 3408/4885CYP1A1 102/4885CYP1A2 902/4885 |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | CYC1, CCNA1, CYCS | ACHE 3408/4885CYP1A1 102/4885CYP1A2 902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.